Stock Charts
HOME
WATCHLIST
PORTFOLIO
114
SUMMARY
INDICES
SECTORS
MOVERS
RATES
FUTURES
JOBS
Symbol Lookup
WallStreetSelect 114
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
Allergan, Inc.
(NY:
AGN
)
97.96
USD
+0.23 (+0.24%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Allergan, Inc.
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
WallStSense.com Fundamental & Technical Coverage of AGN, PPG, EPI, AGNC, IBN and AKS
October 07, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com
Read More
from
Marketwired News Releases
Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of BOTOX® for Common Therapeutic Off-Label Treatments
October 01, 2009
from
Business Wire News Releases
Allergan Announces Quarterly Conference Call
September 30, 2009
from
Business Wire News Releases
Critical Alerts for Apple, Alcoa, CarMax, Allergan, and AnnTaylor Released by Seven Summits Research
September 29, 2009
from
PR Newswire
Quintiles and Allergan Announce Co-Promotion for Sanctura XR®
September 25, 2009
Agreement to Extend Sales Force Capacity and Reach in Primary Care Channel
Read More
from
Business Wire News Releases
AnalystChoice.com Brings You the Best Complimentary Research Report on AGN, CVS, KR, BRO, MWW and APA
September 24, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
Pieris AG Enters into Anticalin Collaboration With Allergan, Inc.
September 15, 2009
from
PR Newswire
TheFortuneFinancial.com Free Market Research on AEE, D, RRI, AMR, COV and AGN
September 11, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.
Read More
from
Marketwired News Releases
Critical Alerts for JPMorgan Chase, Monsanto, Celgene, VMWare, and Allergan Released by Seven Summits Research
August 31, 2009
from
PR Newswire
BenchmarkJournal.com Free Analyst Review for ACN, CHL, L, AGN, BA and AMX
August 28, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal.
Read More
from
Marketwired News Releases
RothmanResearch.com Stock Review for DAN, PG, MON, DDR, PNR and AGN
August 14, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by RothmanResearch.com.
Read More
from
Marketwired News Releases
StockPreacher.com issues Trading Outlook for Spectrum Pharmaceuticals Inc.
August 05, 2009
from
GlobeNewswire News Releases
StreetInvesting.com Free Research on AGN, DAL, CYH, GNA, JBL and DT
August 04, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by StreetInvesting.com (SI).
Read More
from
Marketwired News Releases
Allergan Reports Second Quarter 2009 Operating Results
July 31, 2009
from
Business Wire News Releases
ParagonReport.com Complimentary Earnings Analysis on DRYS, CVX, D and AGN
July 30, 2009
Note to editors: The Following Is an Investment Opinion Being Issued by the Paragon Financial Report
Read More
from
Marketwired News Releases
Allergan Receives FDA Approval for ACUVAIL™ Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
July 23, 2009
from
Business Wire News Releases
FDA Designates Fast Track Status for Apaziquone (EOquin®) for Bladder Cancer
July 21, 2009
from
Business Wire News Releases
AnalystChoice.com Brings You the Best Complimentary Research Report on CP, EOG, GNW, AGN, D and IFF
July 17, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
Allergan Announces Quarterly Conference Call
July 06, 2009
from
Business Wire News Releases
WallStSense.com Fundamental & Technical Coverage of FHN, KSS, MRK, WEL, AGN and SLG
July 06, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com
Read More
from
Marketwired News Releases
Allergan Receives FDA Approval for OZURDEX™ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
June 18, 2009
from
Business Wire News Releases
TheFortuneFinancial.com Free Market Research on AGN, CHL, ECL and GFG
June 17, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.
Read More
from
Marketwired News Releases
Oceana Therapeutics Completes Transaction for Rights to Deflux and Solesta; Company Achieves Key Growth Milestone Despite Challenging Economic Environment
June 04, 2009
from
Business Wire News Releases
MaybachFinancial.com Posts Free Analyst Report on CIM, AGN, BPO and BYD
May 27, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Maybach
Read More
from
Marketwired News Releases
Allergan Receives Complete Response Letter for BOTOX® (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults
May 26, 2009
from
Business Wire News Releases
VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing $250,000 to the Not-For-Profit Dress for Success
May 15, 2009
from
PR Newswire
Schaeffer's Option Blog: Allergan, Inc. (AGN) Attacked by Bears on Botox Bulletin, Earnings
May 01, 2009
from
Business Wire News Releases
AnalystChoice.com Free Investment Opinion on HIG, AGN, BDX and BXP
May 01, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
Allergan Reports First Quarter 2009 Operating Results
May 01, 2009
from
Business Wire News Releases
Allergan Comments on Today’s Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency’s Safety Review of Botulinum Toxins
April 30, 2009
from
Business Wire News Releases
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here